Sign In
Buy TLSA
$1.03
+0.0600 (+6.19%)
At Close: Jul 31, 2026
Precision Gains Access to Tiziana's Anti-CD3 Antibody, Foralumab, to Evaluate as a Lymphodepletion Agent with its Allogeneic CAR T Portfolio Precision Gains Access to Tiziana's Anti-CD3 Antibody, Fora
Tiziana Life Sciences set for Nasdaq move
06:08am, Friday, 20'th Aug 2021
Tiziana Life Sciences Plc told investors it has formally begun its strategic plan to change its corporate structure. It has established a Bermuda-incorporated company Tiziana Life Sciences Ltd which i
LONDON and NEW YORK, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Old Tiziana") a biotechnology company focused on innovative therapeutics for oncology, inf
Los Angeles, California--(Newsfile Corp. - August 18, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Te
A peer-reviewed scientific article has underscored the potential of Tiziana Life Sciences PLC (LSE:TILS, NASDAQ:TLSA, FRA:RTRA, OTC:TIZAF)'s monoclonal antibody nasal spray in people with mild-to-mode
Tiziana Life Sciences upbeat on potential for coronavirus treatment
02:45am, Tuesday, 17'th Aug 2021
How it is doing Shares have soared recently on the potential for Tiziana's (LON:TILS) TZLS-501 to be useful for people severely ill with coronavirus-related complications. TZLS-501 is a class of monoc
A peer-reviewed scientific article has underscored the potential of Tiziana Life Sciences PLC's (NASDAQ:TLSA, LON:TILS) monoclonal antibody nasal spray in people with mild-to-moderate Covid. The repor
NEW YORK and LONDON, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for
Tiziana Life Sciences plc Invites You to Join Us at the Q3 Virtual Investor Summit
01:14pm, Monday, 16'th Aug 2021
London, United Kingdom--(Newsfile Corp. - August 16, 2021) - Tiziana Life Sciences plc (NASDAQ:TLSA) today announced that Dr. Kunwar Shailubhai, CEO & CSO will be attending the Q3 Virtual Investor Sum
Why Tiziana Life Sciences Shares Are Trading Higher Today
03:19pm, Friday, 23'rd Jul 2021
Tiziana Life Sciences (NASDAQ: TLSA) shares are trading higher by 16% at $2.10 as traders circulate a June 17 press release from the company titled 'Tiziana Responds to UK Call for Development of Inn
Tiziana Life Sciences plc - ADS Ex-Dividend Date Scheduled for July 09, 2021
07:59am, Thursday, 08'th Jul 2021
THIS ANNOUNCEMENT IS FOR US ADS HOLDERS ONLY
Tiziana Life Sciences plc - Distribution Dates for shares and ADRs in Accustem Sciences Limited
07:58am, Friday, 02'nd Jul 2021
LONDON and NEW YORK, July 02, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for
Dr Howard Weiner, Chairman of the Tiziana Scientific Advisory Board, to give an interview on Bloomberg Markets at 1.50pm ET today
06:47am, Wednesday, 30'th Jun 2021
NEW YORK and LONDON, June 30, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA, LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation and in
Tiziana Life Sciences plc (the "Company") Result of Annual General Meeting
06:15am, Friday, 25'th Jun 2021
LONDON, June 25, 2021 (GLOBE NEWSWIRE) -- At the Annual General Meeting of the Company held at 10.00 a.m. on 25 June 2021, all of the resolutions were duly passed.
TLSA Stock Price Increases Over 6% Pre-Market: Why It Happened
07:39am, Wednesday, 23'rd Jun 2021
The stock price of Tiziana Life Sciences plc (NASDAQ: TLSA) increased by over 6% pre-market. This is why it happened.
